Monday, November 25, 2019 2:34:22 AM
CV Sciences faces two significant headwinds that Charlotte's Web does not:
But, regarding 2., I believe it's more than just the wording, now and IN THE FUTURE.
1. Lack of brand differentiation -
Every "<whatever>CBD" upstart product looks and sounds
a lot like "PlusCBD"
2. "CBD" incorporated in the brandname -
which prompts some retailers who sell in states that
restrict CBD in ingestibles to avoid those products.
Those states are approximately 1/3 of USA population.
For example, The Vitamin Shoppe
"CBD" has been identified by the FDA as a drug. That is NOT SO for "Hemp Extract" with more than 80 naturally occurring phytocannabinoids, including CBD, and other beneficial plant compounds.
So Charlotte's patented hemp cultivar with naturally occurring high levels of CBD is very important.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM